Neuroendocrine Tumors and Carcinoid Syndrome. Reimbursement Considerations in an Evolving Landscape
Recorded on August 1, 2019
Sponsored by Lexicon
An overview of Neuroendocrine Tumors and Carcinoid Syndrome, and pharmacological agents used for treatment. With varying types of managed care coverage (medical and pharmacy benefit) available for these agents, utilization management criteria and payer tactics will be examined in a case study.
Richard Cook, PharmD
This webinar is sponsored, developed and presented by the sponsor. The content of the Science & Innovation Theater Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of the Academy of Managed Care Pharmacy.